Validation of the 7th TNM classification for non-small cell lung cancer: A retrospective analysis on prognostic implications for operated node-negative cases

Acta Oncologica

Volumn 52, Issue 6, 2013, Pages 1189-1194

  Bergman, Per ^a,b   Brodin, Daniel ^a   Lewensohn, Rolf ^a,b   De Petris, Luigi ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LOBECTOMY; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; REGISTER; RETROSPECTIVE STUDY; SMOKING; SURVIVAL RATE; VALIDATION STUDY; DISEASE SEVERITY; LUNG ADENOCARCINOMA; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 84880307380     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2012.742960     Document Type: Article

References (27)

1. Globocan 2008. Available from: H ttp://www.globocan.iarc.fr [cited 25 June 2012].
2. The national lung cancer registry in Sweden. A vailable from: Http://www.roc.se/lungca.asp [cited 25 June 2012].
3. Groome PA, Bolejack V, Crowley JJ, Kennedy C, Krasnik M, Sobin LH, et al. The IASLC Lung Cancer Staging Project: Validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classifi cation of malignant tumours. J Thorac Oncol 2007; 2: 694-705.
4. Mountain C F. R evisions in the international system for staging lung cancer. CHEST 1997; 111: 1710-7.
5. Rami-Porta R, Ball D, Crowley J, Giroux D J, Jett J, Travis W D, et al. The IASLC Lung Cancer Staging Project: Proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classifi cation for lung cancer. J Thorac Oncol 2007; 2: 593-602.
6. Goldstraw P, Crowley J J, Chansky K, Giroux D J, Groome P A, Rami-Porta R, et al. The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classifi cation of malignant tumours. J Thorac Oncol 2007; 2: 706-142.
7. Arriagada R, Auperin A, Burdett S, Higgins J P, Johnson D H, Le Chevalier, et al. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: Two meta-analyses of individual patient data. NSCLC Metaanalyses Collaborative Group. Lancet 2010; 375: 1267-77.
8. Rekhtman N. N euroendocrine tumors of the lung: An update. Arch Pathol Lab Med 2010; 134: 1628-38.
9. Fischer B, Lassen U, Mortensen J, Larsen S, Loft A, Bertelsen A, et al. Preoperative staging of lung cancer with combined PET-CT. N Engl J Med 2009; 361: 32-9.
10. Shiono S, Abiko M, Sato T. P ositron emission tomography/computed tomography and lymphovascular invasion predicts recurrence in stage I lung cancers. J Thorac Oncol 2011; 6: 43-7.
11. Pignon J P, Tribodet H, Scagliotti G V, Douillard J Y, Shepherd FA, Stephens RJ, et al. Lung adjuvant cisplatin evaluation: A pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008; 26: 3552-9.
12. Manac ́ h D, Riquet M, Medioni J, Le Pimpéc-Barthes F, Dujon A, Danel C. Visceral pleura invasion by non-small cell lung cancer: An underrated bad prognostic factor. Ann Thorac Surg 2001; 71: 1088-93.
13. Shimizu K, Yoshida J, Nagai K, Nishimura M, Ishii G, Morishita Y, et al. Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer. J Thorac Cardiovasc Surg 2005; 130: 160-5.
14. Li Z, Y u Y, L u J, Luo Q, W u C, Liao M, et al. A nalysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China. J Thorac Oncol 2009; 4: 702-9.
15. Lardinois D, De Leyn, Van Schil P, Rami Porta R, Waller D, Passlick B, et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg 2006; 30: 787-92.
16. Darling GE, Allen MS, Decker PA, Ballman K, Malthaner RA, Inculet RI, et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: Results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg 2011; 141: 662-70.
17. Kameyama K, Takahashi M, Ohata K, Igai H, Yamashina A, Matsuoka T, et al. Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single Institution. J Thorac Cardiovasc Surg 2009; 137: 1180-4.
18. Kassis ES, Vaporciyan AA, Swisher SG, Correa AM, Bekele BN, Erasmus JJ, et al. Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population. J Thorac Cardiovasc Surg 2009; 138: 412-8.
19. Yano T. M orodomi Y, Ito K, Yoshida T, Haro A, Shoji F, et a l. Verifi cation of the newly proposed T category (seventh edition of the tumor, node, and metastasis classifi cation from a clinicopathological viewpoint in non-small cell lung cancer-special reference to tumor size. J Thorac Oncol 2010; 5: 45-8.
20. Strand TE, Rostad H, Wentzel-Larsen T, von Plassen C. A population-based evaluation of the seventh edition of the TNM system for lung cancer. Eur Respir J 2010; 36: 401-7.
21. Ruffi ni E, Filosso PL, Bruna MC, Coni F, Cristofori RC, Mossetti C, et al. Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer-Lung Cancer Staging Project: A validation study from a single-centre experience. Eur J Cardiothorac Surg 2009; 36: 1037-44.
22. Veeramachaneni NK, Battafarano RJ, Meyers BF, Bell Zoole J, Patterson GA. Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: A negative impact on survival. Eur J Cardiothorac Surg 2007; 33: 466-9.
23. Patz E F, Rossi S, Harpole D H, Herndon J E, Goodman P C. Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer. Chest 2000; 117: 1568-71.
24. Takeda S, Fukai S, Komatsu H, Memoto E, Nakamura K, Murakami M. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer. Ann Thorac Surg 2005; 79: 1142-6.
25. Ou SH, Zell JA, Ziogas A, Anton-Culver H. P rognostic signifi -cance of the non-sized-based AJCC T2 descriptors: Visceral pleura invasion, hilar atelectasis or obstructive pneumonitis in stage IB, non-small cell lung cancer is dependent on tumor size. Chest 2008; 133: 662-9.
26. Koike T, Yamato Y, Asamura H, Tsuchiya R, Sohara Y, Egushi K, et al. Improvements in surgical results for lung cancer from 1989 to 1999 in Japan. J Thorac Oncol 2009; 4: 1364-9.
27. Ruffi ni E, Asioli S, Filosso PL, Buffoni L, Bruna MC, Mossetti C, et al. Signifi cance of the presence of microscopic vascular invasion after complete resection of stage I-II pT1. T2N0 non-small cell lung cancer and its relation with T-size categories. J Thorac Oncol 2011; 6: 319-26.